Novavax
Sign in to saveAlso known as Novavax (United States)
thumb|Stanley Erck (right) and Gregory Glenn (left) at the biotech labs in Gaithersburg during the visit of the Governor of [[Maryland in September 2020]] thumb|Novavax research and development laboratories in Gaithersburg Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria.
OverviewAI-generated
Novavax is an active operating company established in 1987. It is located in Gaithersburg, United States, and is incorporated in Delaware. The organization functions as both a company and a funder within the biological products sector, specifically excluding diagnostic substances.
The entity trades on the Nasdaq exchange under the ticker symbol NVAX. Its Standard Industrial Classification code is 2836, and it holds a Central Index Key of 0001000694. The fiscal year ends on December 31. Recent regulatory filings include form 144, with the latest submission dated May 27, 2026.
Synthesized by Vinony from 21 facts across 4 sources: Wikidata, SEC EDGAR, ROR, Firecrawl. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Key facts
- Company.name
- Novavax, Inc.
- Company.logo
- File:Novavax Logo 2025.png
- Company.image_caption
- Novavax headquarters in Gaithersburg
- Company.type
- Public
- Company.area_served
- Worldwide
- Company.industry
- Biotechnology
- Company.products
- Vaccines
- Company.key_people
- John C. Jacobs (CEO)James P. Kelly (CFO)
- Company.revenue
- (2024)
- Company.operating_income
- - (2024)
- Company.net_income
- - (2024)
- Company.assets
- (2024)
- Company.equity
- - (2024)
- Company.num_employees
- 952 (2025)
via Wikipedia infobox
Company
NVAX- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- Nasdaq
- State of incorporation
- DE
- Entity type
- operating
via SEC EDGAR
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1987
- Location
- Gaithersburg, United States
- Status
- Active
GRID grid.436677.7 · ISNI 0000 0004 0410 5272
Official website
Powering What's Possible | Novavax
Novavax is a biotech company with a proven technology, focused on developing our R&D assets and establishing partnerships to help protect health.
novavax.com →Link to the official site · 5,821 chars · not written by Vinony
Wikidata facts
- Instance of
- public company
- Country
- United States
- Headquarters
- Gaithersburg
- Industry
- pharmaceutical industry
- Stock exchange
- Nasdaq
- Legal form
- Delaware corporation
- Official website
- es.novavax.com
- Image
- Novavax research and development.jpg
Show 4 more facts
- inception
- 1987-00-00
- social media followers
- 58151
- product or material produced
- vaccine
- Commons category
- Novavax
via Wikidata · CC0
~6 min read
Encyclopedic overview
9 sectionsContents
- History
- ResVax
- NanoFlu
- Finance and external sponsorships
- COVID-19 vaccine
- Vaccine research and development
- Authorization and application
- References
- External links
[Skip to main content](https://www.novavax.com/#main-content)
Powering what's possible
Excerpted from Wikipedia’s “Novavax” article, available under the CC BY-SA 4.0 licence.
Gallery (3)
On the map
2 mapped locations